EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study

Xiaorui Tian, Yuanzheng Zhao, Yinghui Zhu, Ming Cui

Archives of Gerontology and Geriatrics · 2024

DOI: 10.1016/j.archger.2024.105441 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Archives of Gerontology and Geriatrics, 2024. Verfasst von Xiaorui Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou university, Zhengzhou, China. Electronic address: 18037866351@163.com. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cognitive Dysfunction, Disease Progression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The breakdown of the blood-brain barrier (BBB) is intricately linked to the onset and advancement of cognitive impairment and dementia. This investigation explores the correlation between blood-brain barrier permeability, assessed through the cerebrospinal fluid/serum albumin ratio (QAlb), in a clinical cohort and the evolution of cognitive decline. METHODS: This prospective observational cohort study included 295 participants. Cognitive decline progression was characterized by an escalation in the overall deterioration scale and/or clinical dementia rating scores. The investigation delves into the correlation between blood-brain barrier permeability and the advancement of cognitive impairment among patients. RESULTS: The APOE 4 allele and diabetes mellitus among individuals exhibited increased BBB permeability (P < 0.05). Moreover, AD patients exhibited the highest QAlb levels, signifying elevated BBB permeability compared to individuals with MCI and SCD (P < 0.05). After mean 17 months following up, 117 patients (51.31 %) were identified as experiencing cognitive decline progression, and we found that only AD diagnosis, CDR, and QAlb (All P < 0.05) were significant predictors of cognitive decline progression. CONCLUSION: Our study emphasizes the clinical relevance of QAlb in detecting individuals with an elevated risk of cognitive decline. It suggests that heightened BBB permeability could contribute to clinical deterioration and serves as a plausible therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierCognitive DysfunctionDisease ProgressionHumansMaleFemaleAgedLongitudinal StudiesProspective StudiesSerum AlbuminMiddle AgedRisk FactorsPermeabilityAlzheimer Disease

Stichwörter der Autor:innen

Alzheimer's diseaseBlood-brain barrierCognitionDementiaRiskVascular dementia

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou university, Zhengzhou, China. Electronic address: 18037866351@163.com.
  • Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou university, Zhengzhou, China.

Zitieren

APA

Tian, X., Zhao, Y., Zhu, Y., & Cui, M. (2024). Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study. Archives of Gerontology and Geriatrics. https://doi.org/10.1016/j.archger.2024.105441

Vancouver

Tian X, Zhao Y, Zhu Y, Cui M. Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study. Archives of Gerontology and Geriatrics. 2024. doi:10.1016/j.archger.2024.105441

BibTeX
@article{Tian2024,
  author = {Tian, Xiaorui and Zhao, Yuanzheng and Zhu, Yinghui and Cui, Ming},
  title = {Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study},
  journal = {Archives of Gerontology and Geriatrics},
  year = {2024},
  doi = {10.1016/j.archger.2024.105441}
}
Kostenlos starten →